These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 28811560)

  • 41. An integrated network of microRNA and gene expression in ovarian cancer.
    Quitadamo A; Tian L; Hall B; Shi X
    BMC Bioinformatics; 2015; 16 Suppl 5(Suppl 5):S5. PubMed ID: 25860109
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Identification and characterization of microRNAs in Humulus lupulus using high-throughput sequencing and their response to Citrus bark cracking viroid (CBCVd) infection.
    Mishra AK; Duraisamy GS; Matoušek J; Radisek S; Javornik B; Jakse J
    BMC Genomics; 2016 Nov; 17(1):919. PubMed ID: 27846797
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Regulation of ovarian cancer progression by microRNA-187 through targeting Disabled homolog-2.
    Chao A; Lin CY; Lee YS; Tsai CL; Wei PC; Hsueh S; Wu TI; Tsai CN; Wang CJ; Chao AS; Wang TH; Lai CH
    Oncogene; 2012 Feb; 31(6):764-75. PubMed ID: 21725366
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A systematic study on dysregulated microRNAs in cervical cancer development.
    He Y; Lin J; Ding Y; Liu G; Luo Y; Huang M; Xu C; Kim TK; Etheridge A; Lin M; Kong D; Wang K
    Int J Cancer; 2016 Mar; 138(6):1312-27. PubMed ID: 26032913
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Gene-microRNA network module analysis for ovarian cancer.
    Zhang S; Ng MK
    BMC Syst Biol; 2016 Dec; 10(Suppl 4):117. PubMed ID: 28155675
    [TBL] [Abstract][Full Text] [Related]  

  • 46. DNA methylation contributes to deregulation of 12 cancer-associated microRNAs and breast cancer progression.
    Pronina IV; Loginov VI; Burdennyy AM; Fridman MV; Senchenko VN; Kazubskaya TP; Kushlinskii NE; Dmitriev AA; Braga EA
    Gene; 2017 Mar; 604():1-8. PubMed ID: 27998789
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Transcriptional and posttranscriptional down-regulation of the imprinted tumor suppressor gene ARHI (DRAS3) in ovarian cancer.
    Lu Z; Luo RZ; Peng H; Rosen DG; Atkinson EN; Warneke C; Huang M; Nishmoto A; Liu J; Liao WS; Yu Y; Bast RC
    Clin Cancer Res; 2006 Apr; 12(8):2404-13. PubMed ID: 16638845
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Identification of the miRNA-mRNA regulatory network of small cell osteosarcoma based on RNA-seq.
    Xie L; Liao Y; Shen L; Hu F; Yu S; Zhou Y; Zhang Y; Yang Y; Li D; Ren M; Yuan Z; Yang Z
    Oncotarget; 2017 Jun; 8(26):42525-42536. PubMed ID: 28477009
    [TBL] [Abstract][Full Text] [Related]  

  • 49. MicroRNAs 125a and 125b inhibit ovarian cancer cells through post-transcriptional inactivation of EIF4EBP1.
    Lee M; Kim EJ; Jeon MJ
    Oncotarget; 2016 Feb; 7(8):8726-42. PubMed ID: 26646586
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The role of microRNAs and nanoparticles in ovarian cancer: a review.
    Kafshdooz L; Pourfathi H; Akbarzadeh A; Kafshdooz T; Razban Z; Sheervalilou R; Ebrahimi Sadr N; Khalilov R; Saghfi S; Kavetskyy T; Mammadova L; Mehrizadeh M; Ghasemali S
    Artif Cells Nanomed Biotechnol; 2018; 46(sup2):241-247. PubMed ID: 29569937
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Overexpression of the microRNA miR-433 promotes resistance to paclitaxel through the induction of cellular senescence in ovarian cancer cells.
    Weiner-Gorzel K; Dempsey E; Milewska M; McGoldrick A; Toh V; Walsh A; Lindsay S; Gubbins L; Cannon A; Sharpe D; O'Sullivan J; Murphy M; Madden SF; Kell M; McCann A; Furlong F
    Cancer Med; 2015 May; 4(5):745-58. PubMed ID: 25684390
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Differential expression of microRNAs and their target genes in non-small-cell lung cancer.
    Lee HY; Han SS; Rhee H; Park JH; Lee JS; Oh YM; Choi SS; Shin SH; Kim WJ
    Mol Med Rep; 2015 Mar; 11(3):2034-40. PubMed ID: 25376560
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The modularity and dynamicity of miRNA-mRNA interactions in high-grade serous ovarian carcinomas and the prognostic implication.
    Zhang W; Edwards A; Fan W; Flemington EK; Zhang K
    Comput Biol Chem; 2016 Aug; 63():3-14. PubMed ID: 26949157
    [TBL] [Abstract][Full Text] [Related]  

  • 54. MicroRNA regulation of progesterone receptor in breast cancer.
    Gilam A; Shai A; Ashkenazi I; Sarid LA; Drobot A; Bickel A; Shomron N
    Oncotarget; 2017 Apr; 8(16):25963-25976. PubMed ID: 28404930
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Five miRNAs considered as molecular targets for predicting neuroglioma.
    Yang H; Wang Y
    Tumour Biol; 2016 Jan; 37(1):1051-9. PubMed ID: 26269115
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Identification of novel and differentially expressed MicroRNAs in goat enzootic nasal adenocarcinoma.
    Wang B; Ye N; Cao SJ; Wen XT; Huang Y; Yan QG
    BMC Genomics; 2016 Nov; 17(1):896. PubMed ID: 27825300
    [TBL] [Abstract][Full Text] [Related]  

  • 57. BAG3 promotes proliferation of ovarian cancer cells via post-transcriptional regulation of Skp2 expression.
    Yan J; Liu C; Jiang JY; Liu H; Li C; Li XY; Yuan Y; Zong ZH; Wang HQ
    Biochim Biophys Acta Mol Cell Res; 2017 Oct; 1864(10):1668-1678. PubMed ID: 28624440
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Human kallikrein 8 (hK8/TADG-14) expression is associated with an early clinical stage and favorable prognosis in ovarian cancer.
    Shigemasa K; Tian X; Gu L; Tanimoto H; Underwood LJ; O'Brien TJ; Ohama K
    Oncol Rep; 2004 Jun; 11(6):1153-9. PubMed ID: 15138549
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Modeling the combined effect of RNA-binding proteins and microRNAs in post-transcriptional regulation.
    HafezQorani S; Lafzi A; de Bruin RG; van Zonneveld AJ; van der Veer EP; Son YA; Kazan H
    Nucleic Acids Res; 2016 May; 44(9):e83. PubMed ID: 26837572
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Prognostic significance of Dicer expression in ovarian cancer-link to global microRNA changes and oestrogen receptor expression.
    Faggad A; Budczies J; Tchernitsa O; Darb-Esfahani S; Sehouli J; Müller BM; Wirtz R; Chekerov R; Weichert W; Sinn B; Mucha C; Elwali NE; Schäfer R; Dietel M; Denkert C
    J Pathol; 2010 Feb; 220(3):382-91. PubMed ID: 19960504
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.